{
  "trial_id": "NCT02728830",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, sex, performance status (ECOG), histological type of gynecologic cancer, prior treatments, baseline tumor size, baseline immune gene expression, baseline co-stimulatory pathway markers, baseline PD-L1 expression, complete blood count (ANC, platelets, hemoglobin), serum creatinine, creatinine clearance, serum total bilirubin, direct bilirubin, AST, ALT, albumin, INR, PT, aPTT, pregnancy status (for females of childbearing potential).",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Eastern Cooperative Oncology Group Performance Status",
          "performance status (ECOG)"
        ],
        [
          "Histologic Subtype",
          "histological type of gynecologic cancer"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Region of Enrollment",
        "Primary Tumor Site",
        "Tumor Grade at Diagnosis",
        "FIGO Stage of Cancer at Diagnosis",
        "Debulking Surgery"
      ],
      "remaining_candidate_features": [
        "prior treatments",
        "baseline tumor size",
        "baseline immune gene expression",
        "baseline co-stimulatory pathway markers",
        "baseline PD-L1 expression",
        "complete blood count (ANC, platelets, hemoglobin)",
        "serum creatinine",
        "creatinine clearance",
        "serum total bilirubin",
        "direct bilirubin",
        "AST",
        "ALT",
        "albumin",
        "INR",
        "PT",
        "aPTT",
        "pregnancy status (for females of childbearing potential)"
      ]
    },
    "processed-gen-response": "Age, sex, performance status (ECOG), histological type of gynecologic cancer, prior treatments, baseline tumor size, baseline immune gene expression, baseline co-stimulatory pathway markers, baseline PD-L1 expression, complete blood count (ANC, platelets, hemoglobin), serum creatinine, creatinine clearance, serum total bilirubin, direct bilirubin, AST, ALT, albumin, INR, PT, aPTT, pregnancy status (for females of childbearing potential)."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Race/Ethnicity, Customized, Region of Enrollment, ECOG Performance Status, Histological Subtype, Prior Treatment History, Baseline Tumor Characteristics, Baseline Immune Markers, Hemoglobin, Platelet Count, ANC, Serum Creatinine, Serum Bilirubin, AST, ALT, Albumin, INR, aPTT,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Eastern Cooperative Oncology Group Performance Status",
          "ECOG Performance Status"
        ],
        [
          "Histologic Subtype",
          "Histological Subtype"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Ethnicity (NIH/OMB)",
        "Primary Tumor Site",
        "Tumor Grade at Diagnosis",
        "FIGO Stage of Cancer at Diagnosis",
        "Debulking Surgery"
      ],
      "remaining_candidate_features": [
        "Prior Treatment History",
        "Baseline Tumor Characteristics",
        "Baseline Immune Markers",
        "Hemoglobin",
        "Platelet Count",
        "ANC",
        "Serum Creatinine",
        "Serum Bilirubin",
        "AST",
        "ALT",
        "Albumin",
        "INR",
        "aPTT"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Race/Ethnicity, Region of Enrollment, ECOG Performance Status, Histological Subtype, Prior Treatment History, Baseline Tumor Characteristics, Baseline Immune Markers, Hemoglobin, Platelet Count, ANC, Serum Creatinine, Serum Bilirubin, AST, ALT, Albumin, INR, aPTT"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Race/Ethnicity, Customized, Region of Enrollment, ECOG Performance Status, Histological type of gynecologic cancer, Stage of disease, Prior treatment for gynecologic cancer, ANC, Platelets, Hemoglobin, Serum creatinine, Serum total bilirubin, AST, ALT, Albumin, INR or PT, aPTT.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Eastern Cooperative Oncology Group Performance Status",
          "ECOG Performance Status"
        ],
        [
          "Histologic Subtype",
          "Histological type of gynecologic cancer"
        ],
        [
          "FIGO Stage of Cancer at Diagnosis",
          "Stage of disease"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Ethnicity (NIH/OMB)",
        "Primary Tumor Site",
        "Tumor Grade at Diagnosis",
        "Debulking Surgery"
      ],
      "remaining_candidate_features": [
        "Prior treatment for gynecologic cancer",
        "ANC",
        "Platelets",
        "Hemoglobin",
        "Serum creatinine",
        "Serum total bilirubin",
        "AST",
        "ALT",
        "Albumin",
        "INR or PT",
        "aPTT"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Race/Ethnicity, Region of Enrollment, ECOG Performance Status, Histological type of gynecologic cancer, Stage of disease, Prior treatment for gynecologic cancer, ANC, Platelets, Hemoglobin, Serum creatinine, Serum total bilirubin, AST, ALT, Albumin, INR or PT, aPTT."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, ECOG performance status, histological type of gynecologic cancer, disease stage, prior cancer treatment, number of prior cancer treatments, time since diagnosis, time since last treatment, ANC, platelets, hemoglobin, serum creatinine, serum total bilirubin, AST, ALT, albumin, INR, aPTT.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "ethnicity"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Eastern Cooperative Oncology Group Performance Status",
          "ECOG performance status"
        ],
        [
          "Histologic Subtype",
          "histological type of gynecologic cancer"
        ],
        [
          "FIGO Stage of Cancer at Diagnosis",
          "disease stage"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Region of Enrollment",
        "Primary Tumor Site",
        "Tumor Grade at Diagnosis",
        "Debulking Surgery"
      ],
      "remaining_candidate_features": [
        "prior cancer treatment",
        "number of prior cancer treatments",
        "time since diagnosis",
        "time since last treatment",
        "ANC",
        "platelets",
        "hemoglobin",
        "serum creatinine",
        "serum total bilirubin",
        "AST",
        "ALT",
        "albumin",
        "INR",
        "aPTT"
      ]
    },
    "processed-gen-response": "Age, sex, race, ethnicity, ECOG performance status, histological type of gynecologic cancer, disease stage, prior cancer treatment, number of prior cancer treatments, time since diagnosis, time since last treatment, ANC, platelets, hemoglobin, serum creatinine, serum total bilirubin, AST, ALT, albumin, INR, aPTT."
  }
}